Meet HiRO at EANM 2026: Your Partner in Radiopharmaceutical Clinical Development
HiRO is excited to attend the EANM 2026 Annual Congress, taking place October 17-21, 2026 in Vienna, Austria.
As a global CRO with specialized expertise in radiopharmaceutical clinical development, we help sponsors navigate the unique challenges of advancing diagnostic and therapeutic radiopharmaceuticals from early-phase studies through registration.
If you’ll be attending EANM, visit us at Booth #237 to connect with our team and learn how HiRO supports innovative radiopharmaceutical programs worldwide.
Specialized Expertise for Radiopharmaceutical Trials
Radiopharmaceutical studies require a clinical research partner with deep experience in nuclear medicine, molecular imaging, trial logistics, regulatory strategy, and global study execution. HiRO provides tailored solutions designed to support the successful development of:
- Radioligand therapies
- Theranostic products
- Molecular imaging agents
- Diagnostic radiopharmaceuticals
- Oncology-focused radiopharmaceutical programs
Our team combines scientific expertise with operational excellence to help sponsors accelerate development while maintaining the highest standards of quality and compliance.
Meet the HiRO Team at Booth #237
Whether you’re planning an upcoming trial, evaluating CRO partners, or exploring strategies for global study execution, we’d love to connect. Stop by Booth #237 to discuss your development goals and learn how HiRO can support your radiopharmaceutical program.
Schedule a Meeting
Make the most of your time at EANM by scheduling a meeting with our team in advance.
Book a meeting with our team: Connect with the HiRO Team at EANM! – Fill out form
Learn more about HiRO’s Radiopharmaceutical Expertise: Radiopharmaceutical – Global Clinical Research Organization | HiRO
We look forward to connecting with sponsors, researchers, and innovators driving the future of radiopharmaceutical development.
